Investing.com - NuVasive reported on Wednesday third quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
NuVasive announced earnings per share of $0.54 on revenue of $295.3M (NYSE:MMM). Analysts polled by Investing.com anticipated EPS of $0.54 on revenue of $298.74M.
NuVasive shares are up 4.35% from the beginning of the year and are trading at $37.53 , down-from-52-week-high.
NuVasive follows other major Healthcare sector earnings this month
NuVasive's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar